Phenotropil (Fonturacetam) [Phenylpiracetam]

Instructions for Phenotropil (Fonturacetam) [Phenylpiracetam] 30 tablets 100 mg

Description
Round flat-cylindrical tablets from white to white with a yellowish color with bevel and hairline.

Active substances
Fonturacetam
Release Form

Tablets
Composition
One tablet contains:
active substance:
fonturacetam - 100.00 mg;
Auxiliary substances:
K-17 povidone, microcrystalline cellulose, sodium carboxymethyl starch, magnesium stearate.

Pharmacological effect Phenotropil

Nootropic agent
It has a pronounced anti-amnesic effect, activates integrative brain activity, promotes memory consolidation, improves concentration and mental activity, facilitates learning processes, accelerates information transfer between brain hemispheres, increases the resistance of brain tissues to hypoxia and toxic effects, has anticonvulsive effect and anxiolytic activity, regulates activation and inhibition of the CNS, improves mood.

Testimony Phenotropil

• Diseases of the central nervous system of different genesis, especially associated with vascular diseases and disorders of
• metabolic processes in the brain, intoxication (in particular, in post-traumatic conditions and manifestations of chronic
• cerebrovascular insufficiency), accompanied by deterioration of intellectual and mnestic functions, reduction of motor activity.
• Neurotic conditions, which show lethargy, increased exhaustion, decreased psychomotor activity, impaired attention, impaired
• memory.depression, intellectual and mnestic disorders).
• Organopsychotic syndromes that manifest intellectual-mnestic disorders and apatico-abulic phenomena, as well as vialoapathic
• conditions in schizophrenia.
• Convulsive states.
• Obesity (alimentarianism), Learning process violations.
• Mild to moderate depression, prevention of hypoxia, increasing resistance to stress, correction of the functional state of the body in extreme conditions of
• professional activity with the aim of preventing the development of fatigue and increasing mental and physical performance,
• correction of daily biorhythm, inversion of the cycle of "sleep-wakefulness".
• Chronic alcoholism (in order to reduce the occurrence of asthma

Method of use Phenotropil

To increase the efficiency - that - two hundred mg once in the morning hours, for two weeks (for athletes - three days).
The recommended duration of treatment for patients with alimentarno-constitutional obesity is thirty-six ten days at a dose of 100-200 mg once a day (in the morning hours). It is not recommended to take PHENOTROPIL after fifteen hours.

• Nosology (ICD codes)
• E66
• Obesity
• F07
• Personality and behavioural disorders caused by disease, damage or brain dysfunction
• F10.2
• Chronic alcoholism
• F20
• Schizophrenia
• F31
• Bipolar affective disorder
• F32
• Depressive episode
• F33
• Recurrent depressive disorder
• F41.2
• Mixed anxiety and depression
• F43
• Response to severe stress and adaptation disorders
• F48.0
• Neurasthenia
• F48.9
• Neurotic disorder unspecified
• F51.2
• Sleep and wakefulness disorders of inorganic etiology
• F81
• Specific learning skills disorders
• G47.2
• Sleep and wakefulness disorders
• I69
• Effects of cerebrovascular disease
• R25.2
• Cramp and spasm
• R45.3
• Demoralization and Apathy
• T90
• Effects of head injuries
• Z73.0
• Overwork
• Z73.3
• Stress conditions not classified in other headings (physical and mental stress)